West Pharmaceutical Services Inc. (WST) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$416.67 +3.23% NYSE • Public Delayed / 60s Snapshot

West Pharmaceutical Services Inc. (WST) earns a Roarable Rating of B- (Buy) with 70/100 RQD Confidence. High-quality cash engine (36% profit margin, 18% return on capital) with steady institutional support. Even if the broader market gets choppy, the company’s underlying cash engine and big-money support put the odds in buyers’ favor.

ROARABLE B- • BUY Cap $29.32B

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERBUY • B-

2-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

5-PILLAR SNOWFLAKE RADARRw C+ · Rk B

Each axis scored 0–20

12M PRICE TARGET CONE+5.4% Base Target

WHALE OPTIONS TUG-OF-WAR:60% Call Buyers ($3.2M)

40% PutsMax Pain: $408.00

SEC FORM 4 × 13F HEDGE FUNDS × CONGRESSIONAL STOCK ACT

WST Smart-Money Thermometer: BALANCED INSTITUTIONAL POSITIONING

Explore All 13F & Congress Whales →

▲ Disclosed Buys: 0 ($0)▼ Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (WST)

No recent open-market Form 4 cluster sales or emergency dumps flagged on WST. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher & Guest Trading Systems Desk

Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live WST Tape Review)

✓Live breakdown of today’s highest-scoring RQD Green-Light breakouts
✓1 urgent Red-Light accounting trap to cut from your watchlist immediately
✓Bring any ticker to live Q&A—we run it through the 5-Pillar RQD Radar on screen

RQD INSIDER CLUB UPGRADE$49/YEAR

Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?

🤖 Try AI Indicator Builder ($49/yr VIP) →$100K Arena

WST // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +38.65%▲ ASCENDING CHANNEL

2026-10-30O $419.1H $422.1L $407.7C $412.6VOL 1.06M

RES: $463.2SUP: $348.0SMA50: $367.6SMA200: $313.4

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

WST Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 WST Butterfly Map → + Track WST →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

41.2%/yr Implied 5Y Growth

vs. +6.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on WST today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

WST → LLY Confirmed Filing

West Pharmaceutical Services manufactures NovaPure fluoropolymer-coated elastomer plungers and cartridge seals required inside sterile single-dose and multi-dose GLP-1 auto-injector pens.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for WST today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

WST Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Are WST insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies WST leadership and institutional positioning as: BALANCED INSTITUTIONAL POSITIONING.

Direct Sub-Reports: WST RQD Cockpit WST 12M Forecast WST Earnings & Move WST Dividends & DRIP WST Insiders & 13F WST Whale Options WST Profit Sankey WST News & Why